Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
438
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Winncare Group has acquired Mangar Health
Healthcare | Private Equity

Winncare Group has acquired Mangar Health

Winncare Group, a medical equipment manufacturer, has acquired Mangar Health, an inflatable lifting and bathing device manufacturer and supplier. Financial details have not been disclosed.

Learn more
Maabarot Products Ltd. has acquired Laboratoria Natury Sp. z o.o
Agriculture | Consumer & Retail | Food & Beverage | Healthcare

Maabarot Products Ltd. has acquired Laboratoria Natury Sp. z o.o

Maabarot Products Ltd., a company producing and marketing a broad range of nutritional products, has acquired Laboratoria Natury Sp. z o.o, a manufacturer of food supplements, vitamins and minerals in Poland, for US$4.5 million.

Learn more
DPC has been acquired by Innova/6 SCA SICAV-RAIF
Private Equity | Healthcare

DPC has been acquired by Innova/6 SCA SICAV-RAIF

Innova/6 SCA SICAV-RAIF has acquired stakes in three companies operating in the dental services market in Central and Eastern Europe – the Lithuanian chain Clinic DPC and Polish Dentaurus and Medicadent clinics. Innova, in cooperation with the founding doctors, will develop a leading, independent regional dental group.

Learn more
“Our experience with Oaklins has been very positive. The team is exceptional: they are professional, knowledgeable and proactive. They worked closely with us every step of the way through the investment process. We are delighted with the outcome and are looking forward to sustained growth in our business as a result of the investment.”

Niall Corrigan

CEO, Dolmen Engineering

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=PL&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Time to seize opportunities to reshape your industry

FEBRUARY DEAL ACTIVITY: Our activity followed a similar pace to what we saw in the first month of 2023 with 14 transactions closed, of which 13 were M&A deals and one was fundraising, all covering a wide range of industries. More than half of these transactions were cross-border deals, indicating a continuing interest in global expansion.

Learn more

Talk to our local advisors

 Maciej  Szalaj

Maciej Szalaj

Principal
Warsaw, Poland
Oaklins Poland CF

Meet our global industry specialists

 Robert  Boersma

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands
 Dino  Theodorou

Dino Theodorou

Director
Johannesburg, South Africa
Oaklins Grindrod
 Stuart  Goodman

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners
 Michael  Jewell

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital